MANAGEMENT OF POTHAKI (EYE FOLLICLE) WITH AYURVEDIC MANAGEMENT

MANAGEMENT OF POTHAKI WITH LEKHAN WITH SHASHTRA AND HARITAKYADI LEKHAN ANJAN - AN OPEN LABELLED RANDOMIZED COMPARATIVE CLINICAL TRIAl

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/07/035184

Enrollment

Registered

2021-07-27

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H028- Other specified disorders of eyelid

Interventions

Intervention1: Lekhan with Shashtra: Shastra karma with Shefalika Patra in Affected Eyes Route of Administration : Local Dose - once Control Intervention1: Lekhan with Haritakyadi lekhan Anjan: Lekha

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age group between 18-60 years of either sex 2.The patient presenting with signs and symptoms of Pothaki like Srava, Kandu, Guruta, Rakta Sarsapa Sannibha Pidaka with Ruja will be included in the study

Exclusion criteria

Exclusion criteria: 1.Age less than 18 years and more than 60 years. 2.Contraindicated for Anjana 3.Sama Avastha of Netra Ghana Pichchila Srava Ati Kandu Swayathu Mlan Netrata (Tired eye) 4.SYSTAMIC EXCLUSION Bleeding disorders Pregnancy Diabetes mellitus Hypertension Pt. on anti coangluent 5.OPHTHALMIC EXCLUSION Trachoma stage - papillary hypertrophy Trachoma stage - cicatrization Dry eye syndrome Lid disorders like stye, chalazion etc. Chronic conjunctivitis Keratoconjunctivitis Herpes zoster Any type of ocular injury e.g. blunt trauma, including chemical injury

Design outcomes

Primary

Measure	Time frame
Improvement in Symptoms of PothakiTimepoint: upto 14 days	—

Secondary

Measure	Time frame
Improvement in Symptoms of PothakiTimepoint: Patients will be Assessed upto 1 month after Completion of therapy	—

Countries

India

Contacts

Public ContactDr Twinkal Zala

Government Akhandanand Ayurveda Collage and Hospital

dr.hemangishukla@gmail.com9099770978

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026